Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.
| Abstract |
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
|
| Authors | Michael Seimetz, Natascha Sommer, Mariola Bednorz, Oleg Pak, Christine Veith, Stefan Hadzic, Marija Gredic, Nirmal Parajuli, Baktybek Kojonazarov, Simone Kraut, Jochen Wilhelm, Fenja Knoepp, Ingrid Henneke, Alexandra Pichl, Zeki I Kanbagli, Susan Scheibe, Athanasios Fysikopoulos, Cheng-Yu Wu, Walter Klepetko, Peter Jaksch, Christina Eichstaedt, Ekkehard Grünig, Katrin Hinderhofer, Miklós Geiszt, Niklas Müller, Flavia Rezende, Giulia Buchmann, Ilka Wittig, Matthias Hecker, Andreas Hecker, Winfried Padberg, Peter Dorfmüller, Stefan Gattenlöhner, Claus F Vogelmeier, Andreas Günther, Srikanth Karnati, Eveline Baumgart-Vogt, Ralph T Schermuly, Hossein A Ghofrani, Werner Seeger, Katrin Schröder, Friedrich Grimminger, Ralf P Brandes, Norbert Weissmann |
| Journal | Nature metabolism
(Nat Metab)
Vol. 2
Issue 7
Pg. 648
(Jul 2020)
ISSN: 2522-5812 [Electronic] Germany |
| PMID | 32694792
(Publication Type: Published Erratum)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|
